首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   34769篇
  免费   2961篇
  国内免费   1467篇
耳鼻咽喉   546篇
儿科学   657篇
妇产科学   593篇
基础医学   4198篇
口腔科学   619篇
临床医学   3650篇
内科学   5776篇
皮肤病学   799篇
神经病学   2260篇
特种医学   1104篇
外国民族医学   13篇
外科学   4365篇
综合类   4530篇
现状与发展   6篇
一般理论   21篇
预防医学   2130篇
眼科学   1192篇
药学   2838篇
  19篇
中国医学   1210篇
肿瘤学   2671篇
  2024年   69篇
  2023年   452篇
  2022年   1021篇
  2021年   1500篇
  2020年   1106篇
  2019年   1042篇
  2018年   1151篇
  2017年   1038篇
  2016年   1028篇
  2015年   1390篇
  2014年   1702篇
  2013年   1641篇
  2012年   2514篇
  2011年   2536篇
  2010年   1525篇
  2009年   1254篇
  2008年   1798篇
  2007年   1871篇
  2006年   1811篇
  2005年   1783篇
  2004年   1296篇
  2003年   1132篇
  2002年   1034篇
  2001年   851篇
  2000年   863篇
  1999年   824篇
  1998年   456篇
  1997年   391篇
  1996年   292篇
  1995年   313篇
  1994年   255篇
  1993年   187篇
  1992年   338篇
  1991年   304篇
  1990年   297篇
  1989年   272篇
  1988年   227篇
  1987年   224篇
  1986年   205篇
  1985年   157篇
  1984年   110篇
  1983年   82篇
  1981年   57篇
  1979年   77篇
  1978年   54篇
  1977年   55篇
  1976年   50篇
  1974年   67篇
  1973年   64篇
  1972年   70篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
111.
K562/ADM耐药细胞株的建立及其生物学特性的初步观察   总被引:9,自引:2,他引:7  
沈世人  苏颖 《癌症》1992,11(3):222-224
我们建立的K562/ADM耐药细胞株,在ADM浓度为2.4μg/m1(4.46μM)中已稳定培养3.5个月,传了30—35代,K562/ADM亦具有多药耐受件(Multidrug Resistance,MDR)的特点,对ADM、VCR、AT—1258和DDP的耐受性分别为K562的114.7、94.0、13.3和7.4倍,但对5—FU不产生交叉耐药。K562和K562/ADM的倍增时间分别为19.2h和52.8h,集落生成率分别为37.5%和11.1%,K562染色体数为34—68,中位数为56;K562/MDM染色体数为32—90,中位数为50,K562/ADM可做为耐药机理和克服耐药措施研究的极好模型。  相似文献   
112.
One of the most exciting developments in pediatric dermatology has been the use of the flashlamp-pumped, 585-nm, pulsed dye laser for treatment of vascular birthmarks. In many cases the results are miraculous. The increase in self-esteem and happiness of many children and adolescents has been overwhelming; for some, depression has been lifted, stuttering has ceased, social involvement has increased, and antidepressants have been discontinued. There are many success stories to tell.
Despite the remarkable effects of the pulsed dye laser and the medical and psychosocial indications for its use, the issue of pain control remains significant. We have no perfect outpatient pediatric anesthetic. Most methods carry either some risk or, if not hazardous, often are not very effective for controlling pain. Needless to say, a diversity of opinions exist on how to manage discomfort from this treatment modality. Therefore, we thought it would be useful to share the experiences and opinions of several dermatologists who have extensive experience with the pulsed dye laser.  相似文献   
113.
Pulmonary cryptococcosis   总被引:1,自引:0,他引:1  
  相似文献   
114.
用结合^131碘和化疗药物的明胶微球作肝动脉...   总被引:1,自引:0,他引:1  
Nine patients with inoperable hepatoma were treated by using hepatic arterial embolization 131I and chemotherapeutic agent gelatin microsphere (131I-CA-GM). The emission CT after operation detected that the microspheres were concentrated on tumor area. The ratio between the radioactivity in tumor and that in liver was 4.1:1. A case died of ictopic embolization; the others survived 3, 4, 5, 19, 24, 7, 8, and 12 months respectively. Three of them were still alive. 131I-CA-GM has triple anticarcinogenic actions, including the arterial occlusion, targeting chemotherapy and internal radiation. The microspheres can selectively accumulate in the tumor artery and can be easily traced by gamma-camera or emission CT. 131I-CA-GM is a hopeful embolic agent for the treatment of liver cancer, but some problems about ectopic arterial embolization should be further studied.  相似文献   
115.
We report a case of progressive spastic paraparesis in a 45-year-old man with total portal-systemic shunting, which developed spontaneously due to congenital hepatic fibrosis. Cellular functions of the liver, except for an elevated blood ammonia level, were within normal limits, as is usual in congenital hepatic fibrosis. This case shows that spastic paraparesis following portal-systemic shunting may occur without liver failure.  相似文献   
116.
Management and survival of meconium ileus. A 30-year review.   总被引:2,自引:0,他引:2       下载免费PDF全文
Cystic fibrosis patients born with meconium ileus (MI) have had an improved outcome over the last three decades. The authors reviewed the impact of surgical management and long-term nutritional care on the survival of patients with MI. Of the 59 cases of MI seen from 1959 to 1989, 48 cases were managed operatively using either the Bishop-Koop ileostomy (BK), the Mikulicz ileostomy, primary resection and anastomosis (RA), or ileostomy. Six-month survival of MI has improved from 37% to 100%. Nonoperative cases (n = 11) had 100% long-term survival. The RA survivors required less late operative intervention (20%) as compared with other surgical patients (81%). A comparison of serial growth percentiles of CF patients with MI with those of their non-MI CF peers showed similar long-term decreases. These data confirm: (1) There is an improved survival for MI independent of the surgical procedure; (2) The BK ileostomy is an effective and time-tested MI treatment; (3) Primary resection and anastomosis in selected cases may have a lower surgical morbidity rate; and (4) Meconium ileus does not adversely affect the long-term nutritional outcome of CF patients.  相似文献   
117.
广西中小学生营养调查与评价   总被引:2,自引:0,他引:2  
本文报道了广西2市4县29所中小学样12498名学生营养调查结果。调查表明:广西学生蛋白质和能量供应不足,平均值分别供给量标准的57.22% ̄82.90%和66.37% ̄80.44%;城市学生身高、体重发育优于农村学生(P〈0.01),有10.30%的学生患有不同程度的营养缺乏症,且绝大多数是农村学生;学生贫血率为25.46%,城市学生以小细胞性贫血为主,占74.87%,而农村学生的大细胞和小细胞  相似文献   
118.
119.
报告80例经CT诊断的慢性硬脑膜下血肿,其中低密度血肿39例,等密度23例.混合密度16例,高密度2例。混合密度中有11例具有沉积征象,虽然这一征象仅仅见于一小部分病人,但这一特征说明病人有再出血和预示病情恶化的可能。等密度血肿不易识别,容易漏诊或误诊,增强扫描及血管造影将有助于等密度血肿的确诊。  相似文献   
120.
胃癌单克隆抗体-丝裂霉素C结合物的制备及其细胞毒特征   总被引:1,自引:1,他引:0  
作者报道胃癌单克隆抗体MG11-丝裂霉素C(MMC)结合物的制备及其对肿瘤细胞的杀伤作用。首先用戊二酐处理MMC,于MMC上引入羧基,MMC衍生物与N羟基琥珀酰亚胺及2,2′-二环已基碳二亚胺反应,得到MMC活性酯,后者与抗体反应将MMC引入抗体中。经测定,每克分子抗体中引入约6~7克分子药物,结合物对人胃癌细胞KATⅢ具有较强的选择性杀伤作用,在0.56μg/ml水平(药物浓度)对肿瘤细胞杀伤牢达60%,优于游离药物(51%)及无关抗体结合物(9.3%),提示选用的胃癌单抗对MMC具有较好的导向作用。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号